benzbromarone has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, P | 1 |
| Zhu, JJ | 1 |
| Wang, T | 1 |
| Huang, Q | 1 |
| Zhou, YR | 1 |
| Yu, BW | 1 |
| Jiang, HL | 1 |
| Wang, HY | 1 |
1 other study available for benzbromarone and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Benzbromarone aggravates hepatic steatosis in obese individuals.
Topics: Adult; Aged; Animals; Apoptosis; Benzbromarone; Chemical and Drug Induced Liver Injury; Diet, High-F | 2018 |